Five things for pharma marketers to know:
- The U.S. Centers for Medicare and Medicaid Services changed a policy that allowed only a single amyloid PET brain scan per patient per lifetime.
- One week after a three-day walkout that affected service at hospitals and clinics in its network, Kaiser Permanente tentatively agreed to a deal with more than 75,000 healthcare workers.
- The Food and Drug Administration has approved Pfizer’s etrasimod for the treatment of moderate to severe ulcerative colitis.
- New research revealed that some coma patients may in fact be conscious of their surroundings.
- Four months ago, the Food and Drug Administration blocked imports of top-selling Chinese disposable e-cigarette Elf Bar.
